XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-based compensation  
Schedule of stock option activity

For the Year Ended December 31, 2024

    

Options

    

Weighted-
Average
Exercise
Price

    

Aggregate Intrinsic Value
(in thousands)

Weighted-
Average Remaining Contractual Life

Total options outstanding, beginning of period (1)

16,087,146

$

55.48

Granted (2)

    

7,055,206

$

14.43

Exercised

(315,595)

$

14.16

Forfeited and cancelled (3)

(9,267,724)

$

41.58

Total options outstanding, end of period

13,559,033

$

44.58

$

59,949

7.32

Performance/market based options outstanding, end of period (4)

4,300,088

$

84.39

Exercisable, end of period

3,606,304

$

43.15

$

13,075

6.18

(1)The beginning of period weighted-average exercise price for the year ended December 31, 2024 of $55.48 does not reflect the Exchange Offer, which occurred subsequent to December 31, 2023.
(2)Includes approximately 6 million stock options granted in connection with the Exchange Offer.
(3)Includes approximately 7 million stock options cancelled in connection with the Exchange Offer.
(4)These stock options are included in the caption “Total options outstanding, end of period.” See discussion of the 2017 LTIP, 2019 LTIP, 2022 Incentive Plan and Ergen 2020 Performance Award below.
Schedule of realized tax benefits from stock awards exercised

For the Years Ended December 31,

    

2024

    

2023

    

2022

 

(In thousands)

Tax benefit from stock awards exercised

$

2,150

$

1,384

$

573

Schedule of restricted stock unit activity

For the Year Ended 

December 31, 2024

    

Restricted
Stock
Units/Awards

    

Weighted-
Average
Grant Date
Fair Value

    

Total restricted stock units/awards outstanding, beginning of period

    

48,645

$

98.78

Granted

342,602

$

16.60

Vested

(293,001)

$

22.78

Forfeited and cancelled

(7,018)

$

101.09

Total restricted stock units/awards outstanding, end of period

91,228

$

34.08

Schedule of stock options and restricted stock units and awards

For the Years Ended December 31,

    

2024

    

2023

    

2022

 

(In thousands, except per share amounts)

Stock options:

Weighted-average grant date fair value of options granted

$

14.43

$

22.28

$

53.20

Intrinsic value of options exercised

$

2,275

$

$

98

Restricted stock units and awards:

Weighted-average grant date fair value of units and awards granted

$

16.60

$

17.50

$

40.06

Fair value of units and rewards vested

$

6,469

$

9,926

$

2,212

Schedule of non-cash, stock-based compensation expense recognized

For the Years Ended December 31,

Non-Cash, Stock-Based Compensation Expense Recognized (1)

    

2024

    

2023

    

2022

 

(In thousands)

2022 Incentive Plan

$

1,149

$

7,346

$

19,088

2019 LTIP

(1,903)

(97)

Ergen 2020 Performance Award

10,816

12,308

12,308

Other employee performance awards

462

4,502

Total non-cash, stock-based compensation expense recognized for performance based awards

$

11,965

$

18,213

$

35,801

(1)“Non-Cash, Stock-Based Compensation Expense Recognized” includes actual forfeitures.
Schedule of awards outstanding pursuant to performance-based stock incentive plans

As of December 31, 2024

Performance Based Stock Options

    

Number of
Awards

    

Weighted-
Average
Grant Price

 

2022 Incentive Plan

154,257

$

14.64

2019 LTIP

208,024

$

60.37

2017 LTIP

429,037

$

165.32

Ergen 2020 Performance Award

3,508,770

$

78.98

Total

4,300,088

$

84.39

Schedule of allocated non-cash, stock-based compensation expense for all employees

For the Years Ended December 31,

    

2024

    

2023

    

2022

 

(In thousands)

Cost of services

$

1,376

$

2,610

$

6,511

Selling, general and administrative

35,007

48,904

76,483

Total non-cash, stock-based compensation

$

36,383

$

51,514

$

82,994

Schedule of assumptions of Black-Scholes option valuation model

For the Years Ended December 31,

Stock Options

    

2024

    

2023

    

2022

 

Risk-free interest rate

3.58

%  

-

4.49

%  

3.58

%  

-

4.61

%  

1.35

%  

-

4.02

%  

Volatility factor

37.10

%  

-

46.39

%  

34.30

%  

-

41.25

%  

32.67

%  

-

34.84

%  

Expected term of options in years

3.3

-

6.7

4.1

-

6.6

4.1

-

6.0

Fair value of options granted

$

5.15

-

$

12.40

$

7.40

-

$

7.77

$

5.97

-

$

9.27

2022 Incentive Plan, 2019 LTIP, 2013 LTIP and Other  
Share-based compensation  
Schedule of unrecognized non-cash, stock-based compensation expense

Estimated Remaining Non-Cash, Stock-Based Compensation Expense

    

2022 Incentive Plan

    

Ergen 2020 Performance Award

(In thousands)

Expense estimated to be recognized during 2025

$

1,087

$

7,639

Estimated contingent expense subsequent to 2025

161

9,274

Total estimated remaining expense over the term of the plan

$

1,248

$

16,913